Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 4, 2023
Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploringYi Li, Huizhong Zhan, Jufang Wu, et al.The Journal of Infection|January 16, 2021
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjectsXiaofen Liu, Yuancheng Chen, Haijing Yang, et al.Frontiers in Pharmacology|January 2, 2023
Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniaeZhenwei Yu, Xiaofen Liu, Xiaoxing Du, et al.Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.Msphere|October 31, 2023
Comparative efficacy of vancomycin in treating ST5 and ST764 methicillin-resistant Staphylococcus aureus infections in adult patientsYaxin Fan, Kaiting Zhang, Mengting Chen, et al.British Journal of Clinical Pharmacology|April 30, 2021
Nemonoxacin dosage adjustment in patients with severe renal impairment based on population pharmacokinetic and pharmacodynamic analysisYi Li, Jianda Lu, Yue Kang, et al.Journal of Zhejiang University. Science. B|February 8, 2023
Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological SocietyXiaofen Liu, Chenrong Huang, Phillip J Bergen, et al.Pageof 7